Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
Table 1
Clinical characteristic of the study subject.
NCF group (n = 21)
SCF group (n = 44)
value
Clinical and hemodynamic data
Age (years)
58 ± 10
56 ± 8
0.448
Male, n (%)
4 (19)
21 (47.7)
0.026
BMI (kg/m2)
24.03 ± 1.86
24.24 ± 3.09
0.785
Smoking, n (%)
4 (19)
17 (38.6)
0.114
Drinking, n (%)
2 (9.5)
15 (34.1)
0.035
SBP (mmHg)
128 ± 20
127 ± 16
0.883
DBP (mmHg)
75 ± 9
77 ± 10
0.425
HR (bpm)
70 ± 12
71 ± 11
0.650
Hypertension, n (%)
10 (47.6)
18 (40.9)
0.609
DM, n (%)
4 (19)
3 (6.8)
0.137
Hyperlipidemia, n (%)
3 (14.4)
14 (31.8)
0.133
Baseline medication
ARB/ACEI, n (%)
10 (47.6)
24 (54.5)
0.601
BB, n (%)
11 (52.4)
32 (72.7)
0.105
CCB, n (%)
7 (33.3)
16 (36.4)
0.811
Nitrates, n (%)
4 (19)
12 (27.3)
0.472
Statins, n (%)
17 (81)
38 (86.4)
0.572
Antiplatelet agent, n (%)
17 (81)
40 (90.9)
0.253
Anticoagulant, n (%)
3 (14.3)
11 (25)
0.326
Biochemical and hematological data
WBC (109/L)
5.38 ± 1.63
6.16 ± 1.22
0.035
TG (mmol/L)
1.30 ± 0.62
1.68 ± 1.15
0.167
TC (mmol/L)
4.22 ± 0.69
4.16 ± 0.97
0.151
HDL (mmol/L)
1.43 ± 0.41
1.26 ± 0.26
0.087
LDL (mmol/L)
2.40 ± 0.65
2..42 ± 0.80
0.900
FPG (mmol/L)
5.41 ± 0.80
5.16 ± 0.84
0.261
Creatinine (mmol/L)
83.38 ± 30.19
79.94 ± 13.04
0.521
Hs-CRP (mg/L)
2.26 ± 2.30
2.30 ± 3.20
0.956
Data were expressed as mean ± standard error of the mean (SEM) or the number (%) of patients. NCF, normal coronary flow; SCF, slow coronary flow; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; DM, diabetes mellitus; ARB, angiotensin receptor blocker; ACEI, angiotensin converting enzyme inhibitor; BB, beta-blocker; CCB, calcium channel blocker; WBC, white blood cell; TG, triglyceride; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FPG, fasting plasma glucose; Hs-CRP, high-sensitivity C-reactive protein;
